Novo Nordisk pays $26.7 million to settle claims
Saturday, June 11, 2011 - 03:30
in Mathematics & Economics
Danish drug company Novo Nordisk has agreed to pay $25 million to settle allegations that it promoted the misuse of blood clotting drug NovoSeven, the US Justice Department announced Friday.